Breakthrough in treating injuries in horses

A combination of three new osteoarthritis drugs tested by researchers working at the University of Sydney, Australia, can help significantly extend the working life of racing horses and bring many other positive results, while opening up new treatments for inflammatory diseases, joint pain in humans.

This is the combination of 3 different drugs that have been evaluated well in the treatment of osteoarthritis in horses, but this is also one of the first studies to show a combination of 3 different drugs not only has The ability to alleviate pain, but also helps curb the development of arthritis in horses.

Osteoarthritis is a common disease, hampering horse activities
racing as well as reducing their performance in daily events.

" Race horses often suffer from Osteoarthritis, which is also a major cause of waste, significantly affecting the horse industry ," said Toby Koenig, surgeon working at the Animal Teaching Hospital. y, University of Sydney, Australia.

Dr. Koenig leads a clinical trial study at a veterinary hospital's clinical and training research facility, to determine the effects associated with the treatment of osteoarthritis in 16 race horses. is undergoing simulation training.

" We found a combination of three commonly used drugs, including: pentosan polysulphate, glucosamine and hyaluronic acid, which can reduce damage from trauma during strenuous exercise, " said Dr. Koenig. . The results of the study were presented by Dr. Koenig at the Gold Coast conference, Australia, on July 1, 2011.

" Until now, through the experience of focusing on reducing the pain of horses suffering from osteoarthritis. We think the new combination of the three drugs can bring positive effects in the past. horse racing treatment, more flexible, more opportunities to participate in races, training sessions, as well as other sporting events ".

Professor Andrew Dart, Director of Clinical Trials and Dr Koenig, a supervisor, said the study is an important, multi-institutional and international investigation, with major implications not only for horses, but also for other animals.

This study is a bridge between some of the world's leading experts on osteoarthritis, in Australia and the United States. The results of the study not only bring many benefits in the treatment of osteoarthritis in horses, but also promise to bring more broad applicability.

The project co-supervisors are: Professor Leo Jeffcott, former Dean of Veterinary Science, University of Sydney, Australia and the official veterinarian of the horse race in the Olympic Games 5 years ago. year; Associate Professor Chris Little, Director of Raymond Purves Bone Research Laboratory, at the Northern Sydney Royal Hospital, Australia, has worked with researchers to analyze the impact of the three drug combinations. joints of racing horses; Professor Wayne McIlwraith, Director of the Center for Orthopedic Research at Colorado State University, USA and is considered one of the leading specialists in surgery and treatment of osteoarthritis in horses.

The study will be presented at the American University Veterinary Medicine Symposium held in Chicago at the end of 2011.